Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - July 2007

  1. Plans Fall Short on Immunization Rates.   Manag Care; 16 (5): 57; May, 2007.

  2. Pertussis Vaccination of Health Care Workers.   J Occup Environ Med; 49 (6): 700-702; June, 2007.

  3. Abarca, V. K.  [Influenza: Immunization to New Age Groups.].   Rev Chilena Infectol; 24 (3): 227-230; June, 2007.

  4. Abe, M.; Okada, K.; Hayashida, K.; Matsuo, F.; Shiosaki, K.; Miyazaki, C.; Ueda, K.; Kino, Y.  Duration of Neutralizing Antibody Titer After Japanese Encephalitis Vaccination.   Microbiol Immunol; 51 (6): 609-616; 2007.

  5. Al-Tawfiq, J. A.; Abukhamsin, A.  Bordetella Pertussis Infection in a Highly Vaccinated Population in Saudi Arabia, 1996-2004. J Infect; June 11, 2007. [Epub ahead of print].

  6. Anuradha, B.; Santosh, C.; Hari, Sai Priya, V; Suman, Latha G.; Murthy, K.; Vijaya, Lakshmi, V  Age-Related Waning of in Vitro Interferon-Gamma Levels Against R32kDaBCG in BCG Vaccinated Children.   J Immune Based Ther Vaccines; 5: 8; June 7, 2007.

  7. Barr, F.  Rabies Vaccination.   Vet Rec; 160 (24): 850; June 16, 2007.

  8. Beall, B.  Vaccination With the Pneumococcal 7-Valent Conjugate: a Successful Experiment but the Species Is Adapting.   Expert Rev Vaccines; 6 (3): 297-300; June, 2007.

  9. Beigel, J.; Kohl, K. S.; Brinley, F.; Graham, P. L.; Khuri-Bulos, N.; Larussa, P. S.; Nell, P.; Norton, S.; Stoltman, G.; Tebaa, A.; Warschaw, K.  Generalized Vaccinia As an Adverse Event Following Exposure to Vaccinia Virus: Case Definition and Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine; May 2, 2007. [Epub ahead of print].

  10. Bentsi-Enchill, A. D.; Zongo, I.; Khamassi, S.; Pless, R.; Thombiano, R.; Tiendrebeogo, S.; Nelson, C. B.; Duclos, P.  Monitoring of Adverse Events During the 2003 Mass Vaccination Campaign With a Trivalent Meningococcal A/C/W135 Polysaccharide Vaccine in Burkina Faso.   Vaccine; May 7, 2007. [Epub ahead of print].

  11. Boom, J. A.; Dragsbaek, A. C.; Nelson, C. S.  The Success of an Immunization Information System in the Wake of Hurricane Katrina.   Pediatrics; 119 (6): 1213-1217; June, 2007.

  12. Boulanger, J. C.  [About the Opinion of the French Comite Technique Des Vaccinations and Conseil Superieur D'Hygiene Publique (9th March 2007) Concerning Vaccination Against HPV Strains 6, 11, 16 and 18.].   Gynecol Obstet Fertil; 35 (6): 599-600; June, 2007.

  13. Brotherton, J.  HPV Vaccination.    Aust Fam Physician; 36 (6): 391; June, 2007.

  14. Buettcher, M.; Heininger, U.; Braun, M.; Bonhoeffer, J.; Halperin, S.; Heijbel, H.; de Menezes, Martins R.; Vermeer-de, Bondt P.  Hypotonic-Hyporesponsive Episode (HHE) As an Adverse Event Following Immunization in Early Childhood: Case Definition and Guidelines for Data Collection, Analysis, and Presentation.   Vaccine; May 8, 2007. [Epub ahead of print].

  15. Carroll, W.; Burkimsher, R.  Is There Any Evidence for Influenza Vaccination in Children With Asthma?   Arch Dis Child; 92 (7): 644-645; July, 2007.

  16. Chiu, S. S.; Peiris, J. S.; Chan, K. H.; Wong, W. H.; Lau, Y. L.  Immunogenicity and Safety of Intradermal Influenza Immunization at a Reduced Dose in Healthy Children.   Pediatrics; 119 (6): 1076-1082; June, 2007.

  17. Collinson, A.; Harrill, C.; Kealy, M.; Robertson, S.; Sheldon, C.  Mycobacterium Bovis: Guidance on BCG Vaccination Is Needed.   Lancet; 369 (9579): 2076-2077; June 23, 2007.

  18. Crowe, J. E., Jr.  Genetic Predisposition for Adverse Events After Vaccination.   J Infect Dis; 196 (2): 176-177; July 15, 2007.

  19. Daley, M. F.; Crane, L. A.; Chandramouli, V.; Beaty, B. L.; Barrow, J.; Allred, N.; Berman, S.; Kempe, A.  Misperceptions About Influenza Vaccination Among Parents of Healthy Young Children.   Clin Pediatr (Phila); 46 (5): 408-417; June, 2007.

  20. Daniels, N. A.; Juarbe, T.; Moreno-John, G.; Perez-Stable, E. J.  Effectiveness of Adult Vaccination Programs in Faith-Based Organizations.   Ethn Dis; 17 (1 Suppl 1): S15-S22; 2007.

  21. De Wals, P.; Coudeville, L.; Trottier, P.; Chevat, C.; Erickson, L. J.; Nguyen, V. H.  Vaccinating Adolescents Against Meningococcal Disease in Canada: A Cost-Effectiveness Analysis.   Vaccine; 25(29): 5433-40; May 15, 2007.

  22. Dombkowski, K.  School-Based Influenza Vaccination Program Reduces Influenza-Related Outcomes Among Household Members.   J Pediatr; 151 (1): 100; July, 2007.

  23. Donalisio, M. R.; Rodrigues, S. M.; Mendes, E. T.; Krutman, M.  Adverse Events After Pneumococcal Vaccination.   J Bras Pneumol; 33 (1): 51-56; February, 2007.

  24. Englund, J. A.  The Influence of Maternal Immunization on Infant Immune Responses.   J Comp Pathol; 137S1: S16-S19; June 4, 2007.

  25. Esposito, S.; Tremolati, E.; Bellasio, M.; Chiarelli, G.; Marchisio, P.; Tiso, B.; Mosca, F.; Pardi, G.; Principi, N.  Attitudes and Knowledge Regarding Influenza Vaccination Among Hospital Health Workers Caring for Women and Children.   Vaccine; 25(29): 5283-5289; June 4, 2007.

  26. Evers, S. M.; Ament, A. J.; Colombo, G. L.; Konradsen, H. B.; Reinert, R. R.; Sauerland, D.; Wittrup-Jensen, K.; Loiseau, C.; Fedson, D. S.  Cost-Effectiveness of Pneumococcal Vaccination for Prevention of Invasive Pneumococcal Disease in the Elderly: an Update for 10 Western European Countries.   Eur J Clin Microbiol Infect Dis; June 15, 2007. [Epub ahead of print].

  27. Flitter, B. A.; Ismail, A.; Vu, D.; Granoff, D. M.  Group A Antibody Persistence Five Years After Meningococcal Polysaccharide Vaccination in the Sudan.   Hum Vaccin; 3 (4); April 15, 2007.

  28. Funato, M.; Kaneko, H.; Matsui, E.; Teramoto, T.; Kato, Z.; Fukao, T.; Okusu, K.; Kondo, N.  Refractory Osteomyelitis Caused by Bacille Calmette-Guerin Vaccination: a Case Report.   Diagn Microbiol Infect Dis; June 14, 2007. [Epub ahead of print].

  29. Goncalves, G.; Santos, M. A.; Frade, J. G.; Cunha, J. S.  Levels of Diphtheria and Tetanus Specific IgG of Portuguese Adult Women, Before and After Vaccination With Adult Type Td. Duration of Immunity Following Vaccination.   BMC Public Health; 7: 109; June 12, 2007.

  30. Goriely, S.; Goldman, M.  From Tolerance to Autoimmunity: Is There a Risk in Early -SLife Vaccination?   J Comp Pathol; 137S1: S57-S61. June 2, 2007.

  31. Graham, P. L.; Larussa, P. S.; Kohl, K. S.   Robust Take Following Exposure to Vaccinia Virus: Case Definition and Guidelines of Data Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine; May 11, 2007. [Epub ahead of print].

  32. Halperin, S.; Kohl, K. S.; Gidudu, J.; Ball, L.; Hammer, S. J.; Heath, P.; Hennig, R.; Labadie, J.; Rothstein, E.; Schuind, A.; Varricchio, F.; Walop, W.  Cellulitis at Injection Site: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine;  May 11, 2007. [Epub ahead of print].

  33. Jefferson, T.; Demicheli, V.  Influenza Vaccination for Elderly People and Their Care Workers.   Lancet; 369 (9576): 1857-1858; June 2, 2007.

  34. Kantor, I. N.  [Marie Antoinette and the Smallpox Vaccination].   Medicina (B Aires); 67 (2): 206-208; 2007.

  35. Kelly, H. A.; Gidding, H. F.; Karapanagiotidis, T.; Leydon, J. A.; Riddell, M. A.  Residual Susceptibility to Measles Among Young Adults in Victoria, Australia Following a National Targeted Measles-Mumps-Rubella Vaccination Campaign.   BMC Public Health; 7 (1): 99; June 8, 2007.

  36. Kohl, K. S.; Walop, W.; Gidudu, J.; Ball, L.; Halperin, S.; Hammer, S. J.; Heath, P.; Hennig, R.; Rothstein, E.; Schuind, A.; Varricchio, F.  Induration at or Near Injection Site: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine; May 8, 2007. [Epub ahead of print].

  37. Kohl, K. S.; Walop, W.; Gidudu, J.; Ball, L.; Halperin, S.; Hammer, S. J.; Heath, P.; Varricchio, F.; Rothstein, E.; Schuind, A.; Hennig, R.  Swelling at or Near Injection Site: Case Definition and Guidelines for Collection, Analysis and Presentation of Immunization Safety Data.   Vaccine; May 11, 2007. [Epub ahead of print].

  38. Kohl, K. S.; Ball, L.; Gidudu, J.; Hammer, S. J.; Halperin, S.; Heath, P.; Hennig, R.; Labadie, J.; Rothstein, E.; Schuind, A.; Varricchio, F.; Walop, W.  Abscess at Injection Site: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine; [May 11, 2007. [Epub ahead of print].

  39. Kohlhammer, Y.; Schnoor, M.; Schwartz, M.; Raspe, H.; Schafer, T.  Determinants of Influenza and Pneumococcal Vaccination in Elderly People: a Systematic Review.   Public Health;  June 15, 2007. [Epub ahead of print].

  40. Kondro, W.  Progress Report on the National Immunization Strategy.   CMAJ; 176 (13): 1811-1813; June, 2007.

  41. Kroneman, M. W.; van Essen, G. A.  Variations in Influenza Vaccination Coverage Among the High-Risk Population in Sweden in 2003/4 and 2004/5: a Population Survey.   BMC Public Health; 7 (1): 113; June 14, 2007.

  42. Kunze, U.  Tick-Borne Encephalitis: From Epidemiology to Vaccination Recommendations in 2007 New Issues - Best Practices.   Wien Med Wochenschr; 157 (9-10): 228-232; May, 2007.

  43. Landry, P.; Genton, B.  [Immunization Against Yellow Fever].   Rev Med Suisse; 3 (111): 1237-1240; May 16, 2007.

  44. Lawrence, S. J.; Lottenbach, K. R.; Newman, F. K.; Buller, R. M.; Bellone, C. J.; Chen, J. J.; Cohen, G. H.; Eisenberg, R. J.; Belshe, R. B.; Stanley, S. L., Jr.; Frey, S. E.  Antibody Responses to Vaccinia Membrane Proteins After Smallpox Vaccination.   J Infect Dis; 196 (2): 220-229; July 15, 2007.

  45. Lepej, S. Z.; Tesovic, G.; Sternak, S. L.; Jeren, T.  Naive and Memory CD4(+) T-Cells in the Cerebrospinal Fluid of Children With Aseptic Meningitis Following Measles-Mumps-Rubella Vaccination and Enteroviral Meningitis.   Immunol Invest; 36 (3): 321-335; 2007.

  46. Mangrio, N.; Shaikh, B. T.; Alam, M. M.  Issues and Chanllenges in Expanded Programme on Immunization in Sindh, Pakistan.   J Coll Physicians Surg Pak; 17 (5): 308-309; May, 2007.

  47. Mayer, L.  Immunity for Immunizations: Tort Liability, Biodefense, and Bioshield II.   Stanford Law Rev; 59 (6): 1753-1790; April, 2007.

  48. Meisel, R.; Dilloo, D.  Pneumococcal Vaccination of Children After Hematopoietic Stem Cell Transplantation: Timing Is Crucial.   Clin Infect Dis; 45 (3): 397-398; August 1, 2007.

  49. Miranzi, S. D.; Moraes, S. A.; Freitas, I. C.  Impact of the Haemophilus Influenzae Type b Vaccination Program on HIB Meningitis in Brazil.   Cad Saude Publica; 23 (7): 1689-1695; July, 2007.

  50. Mooi, F. R.; de Greeff, S. C.  The Case for Maternal Vaccination Against Pertussis.   Lancet Infect Dis; May 28, 2007. [Epub ahead of print].

  51. Morrow, H.; Collins, B. K.; Smith, D. R.  Public Health Coalitions: Patterns and Perceptions in State Immunization Programs.   J Health Hum Serv Adm; 30 (2): 156-175; 2007.

  52. Nante, J. E.; Diness, B. R.; Ravn, H.; Roth, A.; Aaby, P.; Benn, C. S.  No Adverse Events After Simultaneous Administration of 50 000 IU Vitamin A and Bacille Calmette-Guerin Vaccination to Normal-Birth-Weight Newborns in Guinea-Bissau.   Eur J Clin Nutr; May 30, 2007. [Epub ahead of print].

  53. Navarro-Alonso, J. A.; Bernal-Gonzalez, P. J.; Perez-Martin, J. J.  [Knowledge Gaps Regarding Human Papillomavirus Vaccine Implementation in Ordinary Vaccination Schedules.].   Med Clin (Barc ); 129 (2): 55-60; June 9, 2007.

  54. Nell, P.; Kohl, K. S.; Graham, P. L.; Larussa, P. S.; Marcy, S. M.; Fulginiti, V. A.; Martin, B.; McMahon, A.; Norton, S. A.; Trolin, I.  Progressive Vaccinia As an Adverse Event Following Exposure to Vaccinia Virus: Case Definition and Guidelines of Data Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine; May 4, 2007. [Epub ahead of print].

  55. Nochi, T.; Takagi, H.; Yuki, Y.; Yang, L.; Masumura, T.; Mejima, M.; Nakanishi, U.; Matsumura, A.; Uozumi, A.; Hiroi, T.; Morita, S.; Tanaka, K.; Takaiwa, F.; Kiyono, H.  From the Cover: Rice-Based Mucosal Vaccine As a Global Strategy for Cold-Chain- and Needle-Free Vaccination.   Proc Natl Acad Sci U S A; 104 (26): 10986-10991; June 26, 2007.

  56. Nowalk, M. P.; Lin, C. J.; Zimmerman, R. K.; Ko, F. S.; Hoberman, A.; Zoffel, L.; Kearney, D. H.  Changes in Parents' Perceptions of Infant Influenza Vaccination Over Two Years.   J Natl Med Assoc; 99 (6): 636-641; June, 2007.

  57. Ortqvist, A.; Granath, F.; Askling, J.; Hedlund, J.  Does Influenza Vaccination Among the Elderly Protect Against Death? A Prospective Cohort Study of All Elderly Persons in a Large Geographical Area.   Eur Respir J; May 30, 2007. [Epub ahead of print].

  58. Packard, R. R.; Schlegel, S.; Senouf, D.; Burger, F.; Sigaud, P.; Perneger, T.; Siegrist, C. A.; Mach, F.  Atorvastatin Treatment and Vaccination Efficacy.   J Clin Pharmacol; June 4, 2007. [Epub ahead of print].

  59. Payne, D. C.; Aranas, A.; McNeil, M. M.; Duderstadt, S.; Rose, C. E., Jr.  Concurrent Vaccinations and U.S. Military Hospitalizations.   Ann Epidemiol; June 14, 2007. [Epub ahead of print].

  60. Rendi-Wagner, P.; Paulke-Korinek, M.; Kundi, M.; Wiedermann, U.; Laaber, B.; Kollaritsch, H.  Antibody Persistence Following Booster Vaccination Against Tick-Borne Encephalitis: 3-Year Post-Booster Follow-Up.   Vaccine; 25 (27): 5097-5101; June 28, 2007.

  61. Rezaei, N.; Aghamohammadi, A.; Siadat, S. D.; Nejati, M.; Ahmadi, H.; Moin, M.; Pourpak, Z.; Kamali, S.; Norouzian, D.; Tabaraei, B.; Read, R. C.  Serum Bactericidal Antibody Response to Serogroup C Polysaccharide Meningococcal Vaccination in Children With Primary Antibody Deficiencies.   Vaccine; 25(29): 5308-5314; June 4, 2007.

  62. Riel-Romero, R. M.  Acute Transverse Myelitis in a 7-Month-Old Boy After Diphtheria-Tetanus-Pertussis Immunization.   Spinal Cord; 45 (6): 463; June, 2007.

  63. Sacks, H. S.  Encouraging Influenza Vaccination for Nursing Home Staff Reduced Mortality and Influenza Like Illness in the Residents.   Evid Based Med; 12 (3): 81; June, 2007.

  64. Samuels, R. C.; Liu, J.; Sofis, L. A.; Palfrey, J. S.  Immunizations in Children With Special Health Care Needs in a Medical Home Model of Care.   Matern Child Health J; June, 2007. [Epub ahead of print].

  65. Sejvar, J. J.; Kohl, K. S.; Bilynsky, R.; Blumberg, D.; Cvetkovich, T.; Galama, J.; Gidudu, J.; Katikaneni, L.; Khuri-Bulos, N.; Oleske, J.; Tapiainen, T.; Wiznitzer, M.  Encephalitis, Myelitis, and Acute Disseminated Encephalomyelitis (ADEM): Case Definitions and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data.   Vaccine; May 11, 2007. [Epub ahead of print].

  66. Semba, R. D.; de, Pee S.; Berger, S. G.; Martini, E.; Ricks, M. O.; Bloem, M. W.  Malnutrition and Infectious Disease Morbidity Among Children Missed by the Childhood Immunization Program in Indonesia.   Southeast Asian J Trop Med Public Health; 38 (1): 120-129; January, 2007.

  67. Shah, S. I.  Interpretation of Maternal Influenza Study Should Not Discourage Immunization Efforts.   Arch Pediatr Adolesc Med; 161 (6): 618; June, 2007.

  68. Silber, J. L.; Chan, I. S.; Wang, W. W.; Matthews, H.; Kuter, B. J.  Immunogenicity of Oka/Merck Varicella Vaccine in Children Vaccinated at 12-14 Months of Age Versus 15-23 Months of Age.   Pediatr Infect Dis J; 26 (7): 572-576; July, 2007.

  69. Simpson, E. L.; Hercher, M.; Hammarlund, E. K.; Lewis, M. W.; Slifka, M. K.; Hanifin, J. M.  Cutaneous Responses to Vaccinia in Individuals With Previous Smallpox Vaccination.   J Am Acad Dermatol; June 7, 2007. [Epub ahead of print].

  70. Skull, S. A.; Andrews, R. M.; Byrnes, G. B.; Kelly, H. A.; Nolan, T. M.; Brown, G. V.; Campbell, D. A.  Missed Opportunities to Vaccinate a Cohort of Hospitalised Elderly With Pneumococcal and Influenza Vaccines.   Vaccine; 25 (28): 5146-5154; July 9, 2007.

  71. Smets, F.; Bourgois, A.; Vermylen, C.; Brichard, B.; Slacmuylders, P.; Leyman, S.; Sokal, E.  Randomised Revaccination With Pneumococcal Polysaccharide or Conjugate Vaccine in Asplenic Children Previously Vaccinated With Polysaccharide Vaccine.   Vaccine; 25(29): 5278-5282; June 4, 2007.

  72. Snow, M.  HPV Vaccine: New Treatment for an Old Disease.   Nursing; 37 (3): 67; March, 2007.

  73. Song, J. Y.; Cheong, H. J.; Ha, S. H.; Hwang, I. S.; Kee, S. Y.; Jeong, H. W.; Lee, C. G.; Kim, W. J.  Clinical Impact of Influenza Immunization in Patients With Liver Cirrhosis.   J Clin Virol; 39 (3): 159-163; July, 2007.

  74. Stanley, S. L., Jr.; Frey, S. E.; Taillon-Miller, P.; Guo, J.; Miller, R. D.; Koboldt, D. C.; Elashoff, M.; Christensen, R.; Saccone, N. L.; Belshe, R. B.  The Immunogenetics of Smallpox Vaccination.   J Infect Dis; 196 (2): 212-219; July 15, 2007.

  75. Tapiainen, T.; Prevots, R.; Izurieta, H. S.; Abramson, J.; Bilynsky, R.; Bonhoeffer, J.; Bonnet, M. C.; Center, K.; Galama, J.; Gillard, P.; Griot, M.; Hartmann, K.; Heininger, U.; Hudson, M.; Koller, A.; Khetsuriani, N.; Khuri-Bulos, N.; Marcy, S. M.; Matulionyte, R.; Schondorf, I.; Sejvar, J.; Steele, R.  Aseptic Meningitis: Case Definition and Guidelines for Collection, Analysis and Presentation of Immunization Safety Data.   Vaccine; May 8, 2007. [Epub ahead of print].

  76. Targonski, P. V.; Poland, G. A.  Pneumococcal Vaccination in Adults: Recommendations, Trends, and Prospects.   Cleve Clin J Med; 74 (6): 401-10, 413; June, 2007.

  77. Tesovic, G.; Lesnikar, V.; Begovac, J.  Comment to "Aseptic Meningitis After Vaccination With L-Zagreb Mumps Strain-Virologically Confirmed Cases" Faulty Calculation of Rates.   Vaccine; 25 (28): 5124-5125; July 9, 2007.

  78. Thomas, L. H.; McDiarmid, A.; Kelly, D. F.   Rabies Vaccination.   Vet Rec; 160 (22): 776; June 2, 2007.

  79. Trollfors, B.  General Vaccination of Children Against Varicella?--Yes!   Acta Paediatr; 96 (6): 794-795; June, 2007.

  80. Trollfors, B.; Bergfors, E.  [Aluminum Allergy Following Vaccination Should Be Entitled to Compensation As Drug-Induced Injury].   Lakartidningen; 104 (19): 1533-1534; May 9, 2007.

  81. Vesikari, T.; Sadzot-Delvaux, C.; Rentier, B.; Gershon, A.  Increasing Coverage and Efficiency of Measles, Mumps, and Rubella Vaccine and Introducing Universal Varicella Vaccination in Europe: A Role for the Combined Vaccine.   Pediatr Infect Dis J; 26 (7): 632-638; July, 2007.

  82. Vila-Corcoles, A.; Ochoa, O.; de, Diego C.; Valdivieso, A.; Herreros, I.; Bobe, F.; Alvarez, M.; Juarez, M.; Guinea, I.; Ansa, X.; Saun, N.  Effects of Annual Influenza Vaccination on Winter Mortality in Elderly People With Chronic Pulmonary Disease.   Int J Clin Pract; June 15, 2007. [Epub ahead of print].

  83. Vila, Corcoles A.  [Pneumococcal Vaccination in the Over-65 Population.].   Aten Primaria; 39 (6): 283-284; June 1, 2007.

  84. Vlahov, D.; Coady, M. H.; Ompad, D. C.; Galea, S.  Strategies for Improving Influenza Immunization Rates Among Hard-to-Reach Populations.   J Urban Health; June 12, 2007. [Epub ahead of print].

  85. Wilson, K.  Protecting Vaccine Programs and the Public.   CMAJ; 176 (12): 1681, 1683; June 5, 2007.

  86. Woodard, S.; Archer, L.; Zell, E.; Ronveaux, O.; Birmingham, M.  Design and Simulation Study of the Immunization Data Quality Audit (DQA).   Ann Epidemiol; June 5, 2007. [Epub ahead of print].

  87. Yang, K. S.; Fong, Y. T.; Koh, D.; Lim, M. K.  High Coverage of Influenza Vaccination Among Healthcare Workers Can Be Achieved During Heightened Awareness of Impending Threat.   Ann Acad Med Singapore; 36 (6): 384; June, 2007.